# OnCo record percutaneous-hepatic-perfusion (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/percutaneous-hepatic-perfusion/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "percutaneous-hepatic-perfusion" ;
  schema:name "Percutaneous hepatic perfusion (chemosaturation)"@en ;
  schema:description "Isolating the liver's circulation with catheters and balloons so that high-dose melphalan can be pumped through it and filtered out before it reaches the rest of the body; approved in 2023 for eye melanoma that has spread to the liver."@en ;
  schema:url <https://onco.cc/technologies/percutaneous-hepatic-perfusion/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Hepatic_arterial_infusion> ;
  owl:sameAs <http://www.wikidata.org/entity/Q5731662> ;
  schema:citation <https://doi.org/10.1245/s10434-024-15293-x>, <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Hepzato> ;
  onco:status "approved" ;
  onco:tag "gap-fill" ;
  onco:cancers <https://onco.cc/cancers/uveal-melanoma/>, <https://onco.cc/cancers/cholangiocarcinoma/>, <https://onco.cc/cancers/neuroendocrine/> ;
  onco:sections <https://onco.cc/fronts/devices/>, <https://onco.cc/fronts/surgery/> ;
  onco:technologies <https://onco.cc/technologies/tace/>, <https://onco.cc/technologies/radioembolisation-tare/>, <https://onco.cc/technologies/isolated-limb-perfusion/> ;
  onco:drugs <https://onco.cc/drugs/melphalan/>, <https://onco.cc/drugs/tebentafusp/> ;
  onco:trials <https://onco.cc/trials/nct02678572/>, <https://onco.cc/trials/nct06519266/>, <https://onco.cc/trials/nct05022901/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-zager-ann-surg-oncol/> .